Du är här

2015-09-22

Novavax, Inc.: Novavax to Host 3rd Annual Analyst and Investor Meeting

GAITHERSBURG, Md., Sept. 22, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc.,
(Nasdaq:NVAX) a clinical-stage vaccine company focused on the discovery,
development and commercialization of recombinant nanoparticle vaccines and
adjuvants, today announced that it will host its 3rd annual Analyst and
Investor Meeting on Tuesday, September 29, 2015 from 9:00 a.m. - 11:00 a.m.
ET in New York, NY.

Senior management will conduct a series of presentations to update analysts
and investors on the Company's ongoing clinical development programs. In
addition, a key opinion leader will provide a clinical perspective on
respiratory syncytial virus (RSV) disease.

For additional information and registration, please email
novavax@westwicke.com or call 443-213-0506.

A live webcast of the presentations can be accessed at the following link:

http://edge.media-server.com/m/p/en8imvms

Please allow extra time prior to the webcast to visit the site and download
the streaming media software required to listen to the Internet broadcast.
The webcast and a replay of the presentation will also be accessible under
the "Investors/Events" section of the Novavax website at novavax.com. The
event will be archived on the company's website for 90 days.

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to
delivering novel products to prevent a broad range of infectious diseases.
Our recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the
foundation for groundbreaking innovation that improves global health through
safe and effective vaccines. Additional information about Novavax is
available on the company's website, novavax.com.

Novavax, Inc.

Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer

Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations

ir@novavax.com
240-268-2000

Russo Partners, LLC

David Schull

Todd Davenport, Ph.D.

david.schull@russopartnersllc.com
todd.davenport@russopartnersllc.com
212-845-4271

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novavax, Inc. via Globenewswire

HUG#1953516

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.